Paper3886121
Fundamental studies with cisplatin.
Rosenberg B. Cancer, 1985. Cited by 458 papers, by iCite.
Cite this record
ConductScience Library. Fundamental studies with cisplatin. Papers, record 3886121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3886121
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Carcinogens | |
| Chemical Phenomena | |
| Chemistry | |
| Combined Modality Therapy | |
| Culture Techniques | |
| DNA | |
| Dogs | |
| Drug Administration Schedule | |
| Drug Resistance | |
| Humans | |
| Isomerism | |
| Mice | |
| Mutagens | |
| Rats | |
| Tissue Distribution |
Source PubMed
Cited by93
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 458 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42072663 | A Cisplatin-Based Prodrug Inhibits Nucleotide Excision Repair Independently of Chromatin Accessibility to Overcome Resistance. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072663 | PubMed |
| 41883856 | Metal complexes in medicine: structural scaffolds vs. functional centres. | Chem Sci | 2026 | https://conductscience.org/library/papers/41883856 | PubMed |
| 38799699 | Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38799699 | PubMed |
| 37372996 | Incorporation of N7-Platinated Guanines into Thermus Aquaticus (Taq) DNA Polymerase: Atomistic Insights from Molecular Dynamics Simulations. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37372996 | PubMed |
| 36134830 | Vitamin C (Ascorbic acid) protects from neuropathy caused by cisplatin, through enhanced heat shock protein-70 and reduced oxidant effect. | Rev Assoc Med Bras (1992) | 2022 | https://conductscience.org/library/papers/36134830 | PubMed |
| 35350450 | Comprehensive comparison of theranostic nanoparticles in breast cancer. | Am J Clin Exp Immunol | 2022 | https://conductscience.org/library/papers/35350450 | PubMed |
| 33622870 | Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo. | In Vivo | 2021 | https://conductscience.org/library/papers/33622870 | PubMed |
| 32454754 | An In Vitro Study on the Interactions of Pycnogenol® with Cisplatin in Human Cervical Cancer Cells. | Turk J Pharm Sci | 2020 | https://conductscience.org/library/papers/32454754 | PubMed |
| 31458267 | Metallothionein: An Aggressive Scavenger-The Metabolism of Rhodium(II) Tetraacetate (Rh2(CH3CO2)4). | ACS Omega | 2018 | https://conductscience.org/library/papers/31458267 | PubMed |
| 29963152 | Suppression of chloride voltage-gated channel 3 expression increases sensitivity of human glioma U251 cells to cisplatin through lysosomal dysfunction. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29963152 | PubMed |
| 29619879 | Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding. | Ren Fail | 2018 | https://conductscience.org/library/papers/29619879 | PubMed |
| 28962385 | Biochemical changes associated with ascorbic acid-cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice. | Toxicol Rep | 2015 | https://conductscience.org/library/papers/28962385 | PubMed |
| 28178874 | Ameliorative effects of pine bark extract on cisplatin-induced acute kidney injury in rats. | Ren Fail | 2017 | https://conductscience.org/library/papers/28178874 | PubMed |
| 28123908 | Comparison of different sample preparation methods for platinum determination in cultured cells by graphite furnace atomic absorption spectrometry. | PeerJ | 2017 | https://conductscience.org/library/papers/28123908 | PubMed |
| 27999837 | Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels. | Chem Commun (Camb) | 2017 | https://conductscience.org/library/papers/27999837 | PubMed |
| 27493875 | Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. | J Cachexia Sarcopenia Muscle | 2016 | https://conductscience.org/library/papers/27493875 | PubMed |
| 27252593 | A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity. | Curr Genomics | 2016 | https://conductscience.org/library/papers/27252593 | PubMed |
| 26365295 | Enzyme-Instructed Intracellular Molecular Self-Assembly to Boost Activity of Cisplatin against Drug-Resistant Ovarian Cancer Cells. | Angew Chem Int Ed Engl | 2015 | https://conductscience.org/library/papers/26365295 | PubMed |
| 26164266 | APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER. | Mutat Res | 2015 | https://conductscience.org/library/papers/26164266 | PubMed |
| 26139519 | Therapeutic interventions to disrupt the protein synthetic machinery in melanoma. | Pigment Cell Melanoma Res | 2015 | https://conductscience.org/library/papers/26139519 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3886121
GET https://conductscience.org/api/papers/v1/3886121/cited_by?page=2